Table 3.
Asymptomatic HCM (n = 41) | Symptomatic HCM (n = 46) | p-value | |
Atrial fibrillation | 17 (41%) | 20(43%) | 0.68 |
None | 24(59%) | 26(57%) | 0.97 |
Paroxysmal | 15(37%) | 12(26%) | 0.41 |
Persistent | 2(5%) | 8(17%) | 0.13 |
LV ejection fraction (%) | 60 ± 10 | 58 ± 9.5 | 0.32 |
LV mass (gr·m-2) | 99 ± 30 | 97 ± 34 | 0.84 |
LV end systolic volume (ml·m-2) | 29 ± 13 | 37 ± 13 | 0.04 |
LA volume (ml·m-2) | 48 ± 21 | 59 ± 23 | 0.03 |
Extent of LGE (%) | 6.0 ± 9.0 | 11 ± 13 | 0.03 |
Data are presented as ± standard deviation. Volumes are indexed to body surface area. HCM = hypertrophic cardiomyopathy patients, LA = left atrial. LGE = late gadolinium enhancement, LV = left ventricular